Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metabolome-wide association study on ABCA7 demonstrates a role for ceramide metabolism in impaired cognitive performance and Alzheimer’s disease

View ORCID ProfileAbbas Dehghan, Rui Pinto, Ibrahim Karaman, View ORCID ProfileJian Huang, Brenan R Durainayagam, Sonia Liggi, Luke Whiley, Rima Mustafa, Miia Kivipelto, Alina Solomon, Tiia Ngandu, Takahisa Kanekiyo, Tomonori Aikawa, Elena Chekmeneva, Stephane Camuzeaux, Matthew R. Lewis, Manuja R Kaluarachchi, View ORCID ProfileMohsen Ghanbari, M Arfan Ikram, Elaine Holmes, View ORCID ProfileIoanna Tzoulaki, Paul M. Matthews, Julian L. Griffin, View ORCID ProfilePaul Elliott
doi: https://doi.org/10.1101/2021.04.06.21254991
Abbas Dehghan
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
2MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abbas Dehghan
  • For correspondence: p.elliott@imperial.ac.uk a.dehghan@imperial.ac.uk
Rui Pinto
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ibrahim Karaman
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Huang
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
4Singapore Institute for Clinical Sciences (SICS), Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jian Huang
Brenan R Durainayagam
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
5Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Liggi
5Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke Whiley
6Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia
7Perron Institute for Neurological and Translational Science, Nedlands, Western Australia 6009, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rima Mustafa
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miia Kivipelto
8Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland
9Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
10Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK
11Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alina Solomon
8Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland
10Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK
11Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiia Ngandu
11Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
12Department of Public Health and Welfare, Population Health Unit, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahisa Kanekiyo
13Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomonori Aikawa
13Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Chekmeneva
14National Phenome Centre, Imperial College London, London W12 0NN, United Kingdom
15Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephane Camuzeaux
14National Phenome Centre, Imperial College London, London W12 0NN, United Kingdom
15Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew R. Lewis
14National Phenome Centre, Imperial College London, London W12 0NN, United Kingdom
15Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuja R Kaluarachchi
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
5Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohsen Ghanbari
16Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohsen Ghanbari
M Arfan Ikram
16Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Holmes
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
5Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
6Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia
7Perron Institute for Neurological and Translational Science, Nedlands, Western Australia 6009, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioanna Tzoulaki
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
2MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
17Department of Hygiene and Epidemiology, University of Ioannina Medical School, University Campus Road 455 00, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ioanna Tzoulaki
Paul M. Matthews
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
18Department of Brain Sciences, Department of Medicine, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian L. Griffin
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
5Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Elliott
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK
2MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place, London, UK
3UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Elliott
  • For correspondence: p.elliott@imperial.ac.uk a.dehghan@imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Genome-wide association studies (GWAS) have identified genetic loci associated with risk of Alzheimer’s disease (AD), but underlying mechanisms are largely unknown. We conducted a metabolome-wide association study (MWAS) of AD-associated loci from GWAS using untargeted metabolic profiling (metabolomics) by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). We identified an association of lactosylceramides (LacCer) with AD-related single nucleotide polymorphisms (SNPs) in ABCA7 (P = 5.0x 10−5 to 1.3 x 10−44). We show that plasma LacCer concentrations are associated with cognitive performance in humans and concentrations of sphingomyelins, ceramides, and hexose-ceramides were altered in brain tissue from ABCA7 knock out mice, compared to wild type (WT) (P =0.049 to 1.4 x10−5). We then used Mendelian randomisation to show that the association of LacCer with AD risk is potentially causal. Our work suggests that risk for AD arising from functional variations in ABCA7 are mediated at least in part through ceramides. Modulation of their metabolism or downstream signalling may offer new therapeutic opportunities for AD.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by the UK Dementia Research Institute at Imperial College, which receives its funding from UK DRI Ltd. funded by the UK Medical Research Council, Alzheimers Society and Alzheimers Research UK. AD is funded by a Wellcome Trust seed award (206046/Z/17/Z). RM is funded by the Presidents PhD Scholarship from Imperial College London. PMM acknowledges generous personal and research support from the Edmond J Safra Foundation and Lily Safra and a National Institute for Health Research (NIHR) Senior Investigator Award (to 2020). JLG is funded by the UK Medical Research Council (MRC) (MC_UP_A090_1006, MC_PC_13030, MR/P011705/1, MR/P01836X/1 and MAP UK) and Wellcome Trust (MetaboFlow). MK is funded by the NIHR Imperial Biomedical Research Centre (BRC), Wallenberg Clinical Scholars, Academy of Finland and Swedish Research Council. AS is funded by the Academy of Finland (287490, 294061, 319318), European Research Council (804371), Alzheimerfonden and Region Stockholm ALF (Sweden). This work was supported by the MRC and NIHR [grant number MC_PC_12025]. PE is the director of the MRC Centre for Environment and Health (MR/L01341X/1). He also acknowledges support from the NIHR Health Protection Research Units in Chemical and Radiation Threats and Hazards and in Health Impact of Environmental Hazards. PE is a co-director of the Health Data Research UK London site, which is supported, among others, by MRC, NIHR, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Wellcome Trust, and British Heart Foundation (BHF). PE acknowledges support from the BHF Centre for Research Excellence at Imperial College. Infrastructure support for this research was provided by the NIHR Imperial Biomedical Research Centre (BRC).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

1. Since 1999, the Rotterdam Study is approved by a special permit issued by the Ministry of Health, Welfare, and Sport of The Netherlands (under Article 3 of the Population Screening Act (the WBO, in Dutch)). As such, the Rotterdam Study is exempted from obtaining separate IRB approvals for the sub-studies that are conducted within the framework of the Rotterdam Study. 2. The Airwave study has ethical approval from the National Health Service Multi-site Research Ethics Committee (MREC/13/NW/0588). Each participant provided informed written consent to participate in the study following procedures approved by the MREC. 3. The FINGER has been approved by the coordinating ethics committee of the hospital district for the Helsinki and Uusimaa region. Participants give their written informed consent before enrollment in the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing interests PMM has received consultancy fees from Biogen, Roche, Celgene and Ipsen Pharmaceuticals. He has received honoraria or speakers’ fees from Novartis, Biogen, Neurodiem and Medscape and has received research or educational funds from Biogen, Novartis and GlaxoSmithKline.

Data Availability

The data is available per request. For cohort data, agreement of the cohort management team is needed.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Metabolome-wide association study on ABCA7 demonstrates a role for ceramide metabolism in impaired cognitive performance and Alzheimer’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Metabolome-wide association study on ABCA7 demonstrates a role for ceramide metabolism in impaired cognitive performance and Alzheimer’s disease
Abbas Dehghan, Rui Pinto, Ibrahim Karaman, Jian Huang, Brenan R Durainayagam, Sonia Liggi, Luke Whiley, Rima Mustafa, Miia Kivipelto, Alina Solomon, Tiia Ngandu, Takahisa Kanekiyo, Tomonori Aikawa, Elena Chekmeneva, Stephane Camuzeaux, Matthew R. Lewis, Manuja R Kaluarachchi, Mohsen Ghanbari, M Arfan Ikram, Elaine Holmes, Ioanna Tzoulaki, Paul M. Matthews, Julian L. Griffin, Paul Elliott
medRxiv 2021.04.06.21254991; doi: https://doi.org/10.1101/2021.04.06.21254991
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Metabolome-wide association study on ABCA7 demonstrates a role for ceramide metabolism in impaired cognitive performance and Alzheimer’s disease
Abbas Dehghan, Rui Pinto, Ibrahim Karaman, Jian Huang, Brenan R Durainayagam, Sonia Liggi, Luke Whiley, Rima Mustafa, Miia Kivipelto, Alina Solomon, Tiia Ngandu, Takahisa Kanekiyo, Tomonori Aikawa, Elena Chekmeneva, Stephane Camuzeaux, Matthew R. Lewis, Manuja R Kaluarachchi, Mohsen Ghanbari, M Arfan Ikram, Elaine Holmes, Ioanna Tzoulaki, Paul M. Matthews, Julian L. Griffin, Paul Elliott
medRxiv 2021.04.06.21254991; doi: https://doi.org/10.1101/2021.04.06.21254991

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1291)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3983)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)